Insmed Stock - analyst coverage and sector comparison at week’s end
19.06.2026 - 17:30:14 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:28 CET. Details in the imprint.
Insmed (US4576693075) is ending the week without new market-moving headlines, but the stock’s strong run over the past year keeps it on many biotech watchlists. With no fresh filings or press releases on Friday, investors are weighing valuation, analyst views and sector positioning.
All news and key data on Insmed stock
Recent price moves and analyst reports keep Insmed on the radar of biotech investors looking at rare-disease growth stories.
What the recent trading shows
Insmed shares most recently closed at $95.70 on 06/18/2026 on the Nasdaq, down 2.8% on the day after a stretch of strong gains in prior weeks, according to price data compiled by MarketBeat. MarketBeat quote page for Insmed
That latest close still leaves the stock markedly above levels seen a year ago, reflecting growing investor confidence in Insmed’s late-stage pipeline and commercial progress in rare respiratory diseases.
How Insmed compares with peers this week
In the US biotech space, Insmed sits within the mid-cap rare-disease group, where valuations have expanded alongside positive clinical and regulatory news at several companies over recent quarters. Nasdaq’s overview for Insmed
Against this backdrop, the modest pullback into the weekend looks more like consolidation than a break in the broader uptrend, especially given the lack of new company-specific news on Friday.
What the company sells
Insmed focuses on therapies for serious and rare pulmonary diseases, including chronic lung infections. Its commercial portfolio and late-stage pipeline target conditions with limited existing treatment options, positioning the company as a specialist in complex respiratory care.
Where the stock trades today
Insmed shares (US4576693075) last traded on the Nasdaq at $95.70 as of 06/18/2026, 15:59 Eastern.
Key facts on Insmed stock
- Company: Insmed Inc.
- ISIN: US4576693075
- WKN: 924801
- Ticker: INSM
- Venue: Nasdaq
- Price (as of 06/18/2026, 15:59 Eastern): 95.70 USD
- Market cap: 13.2 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: not a member of the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
